![](/img/cover-not-exists.png)
EORTC (30885) randomised phase III study with recombinant interferon alpha and recombinant interferon alpha and gamma in patients with advanced renal cell carcinoma
De Mulder, PHM, Oosterhof, G, Bouffioux, C, van Oosterom, AT, Vermeylen, K, Sylvester, RVolume:
71
Year:
1995
Language:
english
Pages:
5
DOI:
10.1038/bjc.1995.75
File:
PDF, 982 KB
english, 1995